John Hession Speaking on CFIUS and Cross-Border Biotech Transactions

At the April 9th MassBio event Cross-Border Biotech Transactions: CFIUS and Other Risks, corporate partner John Hession will speak on the risks that early-stage biotech companies face when pursuing strategic alliances with foreign partners or investors. The discussion will center around the Committee on Foreign Investment in the United States' (CFIUS) expansion of its regulation …

Continue reading John Hession Speaking on CFIUS and Cross-Border Biotech Transactions

Register today: Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances 

  The MBBP Life Sciences group will host the panel event Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances on Wednesday, April 3 in our Waltham office. Topics will include upfront license fees, technology access payments, milestone triggers, commercial due diligence fees, clinical trial milestones, royalty rates, and more. …

Continue reading Register today: Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances 

MBBP’s Life Sciences Vector Newsletter, Summer 2017

Our Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL On September 26, corporate partner Mike Jabbawy will take part in the panel “How …

Continue reading MBBP’s Life Sciences Vector Newsletter, Summer 2017

Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Due to overwhelming demand for our April 28 "Strategic Alliances: Pot of Gold or Pretty Poison?" event, we will be holding another round on Wednesday, June 28 at the Cambridge Innovation Center (CIC). Moderated by corporate attorney John Hession, a panel of business development experts will explore various research and collaboration structures, from options to license to comprehensive …

Continue reading Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28